Machine Learning–Based Prediction of Stroke and Systemic Embolism in Patients with Atrial Fibrillation: A Comparative Real-World Study

Background: Risk stratification for ischaemic stroke and systemic embolism in atrial fibrillation (AF) typically relies on clinical scores with predefined predictors. This study compared conventional CHA₂DS₂-VASc scoring with logistic regression and machine learning models using routine clinical data.Methods: A retrospective cohort of 248,500 adults with AF was identified in the TriNetX Global Collaborative Network from 2015 to 2025. Development and validation sets comprised 198,800 and 49,700 individuals, respectively. The primary outcome was ischaemic stroke or systemic embolism within 24 months. Discrimination, calibration, net benefit, and subgroup performance were evaluated.Results: A total of 12,425 events were recorded (5.0% of the baseline cohort); 221,680 participants had ascertainable 24-month outcome status (event proportion, 5.6%). In the validation analysis, XGBoost achieved the highest AUROC (0.842; 95% CI, 0.832–0.852), followed by random forest (0.826), support vector machine (0.811), and logistic regression (0.794), compared with 0.681 for CHA₂DS₂-VASc. The XGBoost–CHA₂DS₂-VASc difference in AUROC was 0.161 (95% CI, 0.145–0.177; p < .001). XGBoost had a Brier score of 0.041 and higher estimated net benefit across the evaluated 2%–15% risk thresholds.Conclusion: In this internal validation study, models incorporating multidimensional clinical data, particularly XGBoost, discriminated thromboembolic events more effectively than the conventional CHA₂DS₂-VASc score. The comparison highlights the potential contribution of clinical and laboratory variables to AF risk prediction; external validation remains necessary before clinical implementation.

Authors

Institutions

Publication Details

Published
2026-11-17
DOI
https://doi.org/10.9734/ajcr/2026/v9i1414
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Machine Learning–Based Prediction of Stroke and Systemic Embolism in Patients with Atrial Fibrillation: A Comparative Real-World Study

Chimaobi Nwevo, Chipuruime I. Ideh, Benjamin O. C. Echendu, Jeffrey Chidumebi Nebonta
4 links
Atrial Fibrillation Management and Outcomes
article

Machine Learning–Based Prediction of Stroke and Systemic Embolism in Patients with Atrial Fibrillation: A Comparative Real-World Study

Chimaobi Nwevo, Chipuruime I. Ideh, Benjamin O. C. Echendu, Jeffrey Chidumebi Nebonta
article en

Abstract

Background: Risk stratification for ischaemic stroke and systemic embolism in atrial fibrillation (AF) typically relies on clinical scores with predefined predictors. This study compared conventional CHA₂DS₂-VASc scoring with logistic regression and machine learning models using routine clinical data.Methods: A retrospective cohort of 248,500 adults with AF was identified in the TriNetX Global Collaborative Network from 2015 to 2025. Development and validation sets comprised 198,800 and 49,700 individuals, respectively. The primary outcome was ischaemic stroke or systemic embolism within 24 months. Discrimination, calibration, net benefit, and subgroup performance were evaluated.Results: A total of 12,425 events were recorded (5.0% of the baseline cohort); 221,680 participants had ascertainable 24-month outcome status (event proportion, 5.6%). In the validation analysis, XGBoost achieved the highest AUROC (0.842; 95% CI, 0.832–0.852), followed by random forest (0.826), support vector machine (0.811), and logistic regression (0.794), compared with 0.681 for CHA₂DS₂-VASc. The XGBoost–CHA₂DS₂-VASc difference in AUROC was 0.161 (95% CI, 0.145–0.177; p < .001). XGBoost had a Brier score of 0.041 and higher estimated net benefit across the evaluated 2%–15% risk thresholds.Conclusion: In this internal validation study, models incorporating multidimensional clinical data, particularly XGBoost, discriminated thromboembolic events more effectively than the conventional CHA₂DS₂-VASc score. The comparison highlights the potential contribution of clinical and laboratory variables to AF risk prediction; external validation remains necessary before clinical implementation.

Vol. 9(1)
Enugu State University of Science and Technology (NG), Imo State University (NG), National Pirogov Memorial Medical University, Vinnytsya (UA)
Good health and well-being
Atrial Fibrillation Management and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon